Your browser doesn't support javascript.
loading
Time­dependent ROC curve analysis to determine the predictive capacity of seven clinical scales for mortality in patients with COVID­19: Study of a hospital cohort with very high mortality.
Mendoza-Hernandez, Martha A; Hernandez-Fuentes, Gustavo A; Sanchez-Ramirez, Carmen A; Rojas-Larios, Fabian; Guzman-Esquivel, Jose; Rodriguez-Sanchez, Iram P; Martinez-Fierro, Margarita L; Cardenas-Rojas, Martha I; De-Leon-Zaragoza, Luis; Trujillo-Hernandez, Benjamin; Fuentes-Murguia, Mercedes; Ochoa-Díaz-López, Héctor; Sánchez-Meza, Karmina; Delgado-Enciso, Ivan.
Afiliação
  • Mendoza-Hernandez MA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Hernandez-Fuentes GA; COVID Unit, General Hospital Number 1, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.
  • Sanchez-Ramirez CA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Rojas-Larios F; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Guzman-Esquivel J; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Rodriguez-Sanchez IP; Clinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.
  • Martinez-Fierro ML; Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, San Nicolas de los Garza 66455, Mexico.
  • Cardenas-Rojas MI; Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.
  • De-Leon-Zaragoza L; Clinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.
  • Trujillo-Hernandez B; Department of Research, Colima Cancerology State Institute, IMSS-Bienestar Colima, Colima 28085, Mexico.
  • Fuentes-Murguia M; Department of Research, Colima Cancerology State Institute, IMSS-Bienestar Colima, Colima 28085, Mexico.
  • Ochoa-Díaz-López H; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Sánchez-Meza K; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Delgado-Enciso I; Department of Health, El Colegio de La Frontera Sur, San Cristóbal de Las Casas, 29290 Chiapas, Mexico.
Biomed Rep ; 20(6): 100, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38765855
ABSTRACT
Clinical data from hospital admissions are typically utilized to determine the prognostic capacity of Coronavirus disease 2019 (COVID-19) indices. However, as disease status and severity markers evolve over time, time-dependent receiver operating characteristic (ROC) curve analysis becomes more appropriate. The present analysis assessed predictive power for death at various time points throughout patient hospitalization. In a cohort study involving 515 hospitalized patients (General Hospital Number 1 of Mexican Social Security Institute, Colima, Mexico from February 2021 to December 2022) with COVID-19, seven severity indices [Pneumonia Severity Index (PSI) PaO2/FiO2 arterial oxygen pressure/fraction of inspired oxygen (Kirby index), the Critical Illness Risk Score (COVID-GRAM), the National Early Warning Score 2 (NEWS-2), the quick Sequential Organ Failure Assessment score (qSOFA), the Fibrosis-4 index (FIB-4) and the Viral Pneumonia Mortality Score (MuLBSTA were evaluated using time-dependent ROC curves. Clinical data were collected at admission and at 2, 4, 6 and 8 days into hospitalization. The study calculated the area under the curve (AUC), sensitivity, specificity, and predictive values for each index at these time points. Mortality was 43.9%. Throughout all time points, NEWS-2 demonstrated the highest predictive power for mortality, as indicated by its AUC values. PSI and COVID-GRAM followed, with predictive power increasing as hospitalization duration progressed. Additionally, NEWS-2 exhibited the highest sensitivity (>96% in all periods) but showed low specificity, which increased from 22.9% at admission to 58.1% by day 8. PSI displayed good predictive capacity from admission to day 6 and excellent predictive power at day 8 and its sensitivity remained >80% throughout all periods, with moderate specificity (70.6-77.3%). COVID-GRAM demonstrated good predictive capacity across all periods, with high sensitivity (84.2-87.3%) but low-to-moderate specificity (61.5-67.6%). The qSOFA index initially had poor predictive power upon admission but improved after 4 days. FIB-4 had a statistically significant predictive capacity in all periods (P=0.001), but with limited clinical value (AUC, 0.639-0.698), and with low sensitivity and specificity. MuLBSTA and IKIRBY exhibited low predictive power at admission and no power after 6 days. In conclusion, in COVID-19 patients with high mortality rates, NEWS-2 and PSI consistently exhibited predictive power for death during hospital stay, with PSI demonstrating the best balance between sensitivity and specificity.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido